Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Cancer Cell(2021)10.1016/j.ccell.2021.05.015Source: DataRank Database

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 154 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access154 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)OA: bronzeTopics (79)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Aljosja Rogiers ORCID,Michael Dewaele ORCID,Julia Femel ORCID,Panagiotis Karras ORCID,Joanna Poźniak ORCID

Live enrichment

PubMed:34143978

Fonds Wetenschappelijk Onderzoek

Grant: 665501

National Institutes of Health

Grant: Foundation?AKUL/13/41

National Institutes of Health

Grant: I001818N

National Institutes of Health

Grant: C14/18/092

National Institutes of Health

Grant: 2015-143

National Institutes of Health

Grant: P30-CA069533

Herculesstichting

Grant: AKUL/13/41

Stichting Tegen Kanker

Grant: 2016-054

KU Leuven

Grant: 16/19/006

Medical Research Council

Grant: MR/L016311/1

MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine

Marie Curie

Grant: H2020-MSCA-IF-2018

Marie Curie

Grant: H2020-MSCA-IF-2019

Lunds Universitet

Grant: MM383

Lunds Universitet

Grant: WM852

Vetenskapsrådet

Grant: 2016-00215

Vetenskapsrådet

Grant: 12J6921N

NCI NIH HHS

Grant: P30 CA069533

Swedish Research Council

Grant: unidentified

unidentified

European Commission

Grant: 896897

Understanding resistance to immune checkpoint inhibitors by mapping the tumor-host ecosystem at single-cell resolution

Vlaams Instituut voor Biotechnologie

Stichting Tegen Kanker

Fonds Wetenschappelijk Onderzoek

Melanoma Research Alliance

KU Leuven

bronzeLicense: Elsevier Non-Commercial

publisherhttp://www.cell.com/article/S1535610821002816/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821002816?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821002816?httpAccept=text/plain

repositoryhttps://lirias.kuleuven.be/bitstream/123456789/676800/2/1-s2.0-S1535610821002816-main.pdf

https://doi.org/10.1016/j.ccell.2021.05.015

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorNeural CrestAnimalsHumansMiceMice, SCIDMelanomaNeoplasm Recurrence, LocalOximesImidazolesPyridonesPyrimidinonesProto-Oncogene Proteins B-rafMitogen-Activated Protein Kinase KinasesAntineoplastic AgentsProtein Kinase InhibitorsXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmFemaleGlial Cell Line-Derived Neurotrophic FactorFocal Adhesion Kinase 1Neoplastic Stem Cells

Keywords

Neural crest stem cellsMinimal Residual DiseaseCutaneous MelanomaTherapy ResistanceSingle-cell SequencingFak SignalingPatient-derived Tumor XenograftsNongenetic ReprogrammingDYNAMICSMice, SCIDTHERAPYDISEASEMiceOximesMelanomaImidazolesSTATEGene Expression Regulation, NeoplasticDIFFERENTIATIONOncologyBRAF INHIBITOR RESISTANCENeural CrestC16/19/006Neoplastic Stem CellsFemaleLife Sciences & BiomedicineSTEM-CELLSProto-Oncogene Proteins B-raf3101 Biochemistry and cell biologyPyridonesAntineoplastic AgentsPyrimidinonesMECHANISMS3211 Oncology and carcinogenesisCell Line, TumorREVEALSAnimalsHumans1112 Oncology and CarcinogenesisOncology & CarcinogenesisGlial Cell Line-Derived Neurotrophic FactorProtein Kinase InhibitorsMitogen-Activated Protein Kinase KinasesScience & TechnologyCell BiologyXenograft Model Antitumor AssaysCancérologieDrug Resistance, NeoplasmFocal Adhesion Kinase 1Biologie cellulaireNeoplasm Recurrence, Local1109 NeurosciencesLEUKEMIA

Sustainable Development Goals

SDG 3: 3. Good health